James McKiernan
CEO, ColumbiaDoctors · New York Presbyterian Hospital
Credentials: · · · ·
History
PresentFaculties of Health Sciences and the Vagelos College of Physicians and Surgeons · New York Presbyterian Hospital
- Present
Vagelos College of Physicians and Surgeons · New York Presbyterian Hospital
- Present
Department of Urology · New York Presbyterian Hospital
1985–1989
Research
Diagnosis and Treatment of Non-Muscle Invasive Bladder Cancer: AUA/SUO Guideline
Systematic review or meta-analysis · The Journal of Urology · 2016 · Last of 13 authors · 1,110 citations
Tumor Evolution and Drug Response in Patient-Derived Organoid Models of Bladder Cancer
Cell · 2018 · 695 citations
A Novel Urine Exosome Gene Expression Assay to Predict High-grade Prostate Cancer at Initial Biopsy
JAMA Oncology · 2016 · First of 14 authors · 522 citations
- MB
100 papers
44 papers · 6 as a resident
30 papers · 21 as a resident
28 papers · 9 as a resident
25 papers
- CO
24 papers
19 papers · 9 as a resident
19 papers · 6 as a resident
Grants
- 2003–2005
General Clinical Research Center
National Center for Research Resources · M01
Project lead · $26.3K · Columbia University Health Sciences
Clinical trials
- 2014–2019
Phase 1/2 Study of ABI-009 in Nonmuscle Invasive Bladder Cancer
Principal investigator · Completed · Phase 1, Phase 2
Aadi Bioscience, Inc.
- 2008–2014
Intravesicular Abraxane for Treatment-Refractory Bladder Cancer
Principal investigator · Completed · Phase 1, Phase 2
Columbia University